The global market for benign breast disease and early breast cancer diagnostics is experiencing rapid growth due to increasing incidences of these conditions worldwide. A key driver of this market is the aging population, coupled with enhanced diagnostic capabilities and technologies. The market is divided into various categories based on product, … Read More